Thermal ablation of hepatocellular carcinoma in patients with abnormal coagulation function

International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Qiannan HuangKai Li

Abstract

To evaluate the safety of thermal ablation for hepatocellular carcinoma (HCC) in patients with abnormal coagulation function. Fifty-seven HCC tumours in 50 patients were treated with thermal ablation. All patients had a meted platelet count <50 × 109/L or international normalised ratio (INR) ≥ 1.7. Gastroscopy before ablation, platelet concentrate or fresh frozen plasma transfusion during ablation and contrast enhanced ultrasoundgraphy (CEUS)-guided ablation to cease needle tract bleeding were performed to reduce haemorrhage. The incidences of haemorrhage and other major complications were recorded and patients were followed up to observe the local tumour progression (LTP), intrahepatic distant recurrence (IDR), overall survival (OS) and recurrence-free survival (RFS) rates. Two incidences of needle tract bleeding and one needle tract bleeding together with bleeding at the suture of the spleen fossa were found. Three needle tract bleeding events were detected by CEUS and ceased after CEUS-guided complementary ablation. CEUS failed to detect bleeding at the suture of the spleen fossa. Therefore, a laparotomy was conducted for haemostasis. No other major complications were found after ablation. The median follow-up periods were 1...Continue Reading

References

Sep 26, 2002·The British Journal of Surgery·S MulierL Michel
Jan 20, 2004·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Hyunchul RhimS Nahum Goldberg
Aug 21, 2008·Journal of Gastroenterology and Hepatology·Hyunchul RhimWon Jae Lee
Mar 5, 2010·The New England Journal of Medicine·Guadalupe Garcia-Tsao, Jaime Bosch
Mar 9, 2010·European Journal of Internal Medicine·Stefania BasiliFrancesco Violi
Oct 23, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sandro RossiCarmine Tinelli
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Dec 12, 2012·Annals of Surgery·Timucin TanerJohn H Donohue
Apr 20, 2013·Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES·Ioannis MaroulisDimitrios Karavias
Feb 18, 2014·Gut·Jordi BruixVincenzo Mazzaferro
Mar 29, 2014·World Journal of Hepatology·Alexandre Zanchenko FonsecaMarcelo Augusto Fontenelle Ribeiro
Oct 7, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chunping WangYongping Yang
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Apr 26, 2015·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·Luyao ZhouMingde Lu
Sep 5, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lesley De PietriErica Villa
Sep 24, 2015·AJR. American Journal of Roentgenology·Chaitanya AhujaMeghna Chadha
Nov 27, 2015·The British Journal of Radiology·Vittorio MieleMargherita Trinci
Mar 26, 2016·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·UNKNOWN Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Med
Dec 13, 2016·British Journal of Anaesthesia·K GhadimiI J Welsby
Feb 9, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Min Woo LeeDavid S K Lu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.